A detailed history of Ccm Investment Advisers LLC transactions in Amgen Inc stock. As of the latest transaction made, Ccm Investment Advisers LLC holds 721 shares of AMGN stock, worth $189,752. This represents 0.03% of its overall portfolio holdings.

Number of Shares
721
Previous 701 2.85%
Holding current value
$189,752
Previous $219,000 5.94%
% of portfolio
0.03%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$309.38 - $337.38 $6,187 - $6,747
20 Added 2.85%
721 $232,000
Q2 2024

Jul 11, 2024

BUY
$262.75 - $319.31 $184,187 - $223,836
701 New
701 $219,000
Q1 2022

May 03, 2022

SELL
$219.27 - $242.57 $203,921 - $225,590
-930 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$198.88 - $227.6 $184,958 - $211,668
930 New
930 $209,000
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $197,411 - $231,291
-930 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $16,643 - $19,395
-75 Reduced 7.46%
930 $231,000
Q4 2020

Feb 25, 2021

SELL
$216.38 - $257.67 $3,245 - $3,865
-15 Reduced 1.47%
1,005 $231,000
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $34,616 - $42,479
-175 Reduced 14.64%
1,020 $240,000
Q1 2020

May 22, 2020

SELL
$182.24 - $241.7 $67,428 - $89,429
-370 Reduced 23.64%
1,195 $242,000
Q4 2019

Feb 20, 2020

SELL
$189.21 - $243.2 $14,001 - $17,996
-74 Reduced 4.51%
1,565 $377,000
Q3 2019

Nov 19, 2019

SELL
$174.11 - $208.62 $42,831 - $51,320
-246 Reduced 13.05%
1,639 $317,000
Q2 2019

Aug 05, 2019

SELL
$166.7 - $195.41 $519,270 - $608,702
-3,115 Reduced 62.3%
1,885 $347,000
Q1 2019

May 02, 2019

SELL
$180.87 - $203.88 $10.6 Million - $11.9 Million
-58,439 Reduced 92.12%
5,000 $949,000
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $1.19 Million - $1.39 Million
6,656 Added 11.72%
63,439 $12.3 Million
Q3 2018

Nov 05, 2018

SELL
$185.29 - $208.89 $216,418 - $243,983
-1,168 Reduced 2.02%
56,783 $11.8 Million
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $289,591 - $325,273
1,744 Added 3.1%
57,951 $10.7 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $189,592 - $221,562
1,119 Added 2.03%
56,207 $9.58 Million
Q4 2017

Feb 22, 2018

SELL
$168.79 - $188.59 $169,465 - $189,344
-1,004 Reduced 1.79%
55,088 $9.58 Million
Q3 2017

Nov 02, 2017

BUY
$167.29 - $191.0 $9.38 Million - $10.7 Million
56,092
56,092 $10.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ccm Investment Advisers LLC Portfolio

Follow Ccm Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.